Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) was down 8.7% during mid-day trading on Wednesday. The stock traded as low as C$6.62 and last traded at C$6.68. 1,522,825 shares were traded during trading, an increase of 20,451% from the average daily volume of 7,410 shares. The stock had previously closed at C$7.32.
Eupraxia Pharmaceuticals Trading Down 1.3%
The business has a fifty day moving average price of C$7.53 and a 200 day moving average price of C$7.04.
Eupraxia Pharmaceuticals Company Profile
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing locally administered therapies for inflammatory and fibrotic diseases. The company’s programs are designed to deliver active pharmaceutical ingredients directly to affected tissues while potentially limiting systemic exposure and associated side effects.
Eupraxia’s development platform uses a proprietary diffusion-based hydrogel technology intended to provide controlled, sustained drug release.
Read More
- Five stocks we like better than Eupraxia Pharmaceuticals
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
